Tibet AIM Pharm Balance Sheet Health
Financial Health criteria checks 6/6
Tibet AIM Pharm has a total shareholder equity of CN¥754.4M and total debt of CN¥11.0M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥938.5M and CN¥184.1M respectively. Tibet AIM Pharm's EBIT is CN¥55.3M making its interest coverage ratio -23.9. It has cash and short-term investments of CN¥410.5M.
Key information
1.5%
Debt to equity ratio
CN¥11.00m
Debt
Interest coverage ratio | -23.9x |
Cash | CN¥410.48m |
Equity | CN¥754.43m |
Total liabilities | CN¥184.12m |
Total assets | CN¥938.54m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002826's short term assets (CN¥505.7M) exceed its short term liabilities (CN¥177.7M).
Long Term Liabilities: 002826's short term assets (CN¥505.7M) exceed its long term liabilities (CN¥6.4M).
Debt to Equity History and Analysis
Debt Level: 002826 has more cash than its total debt.
Reducing Debt: 002826's debt to equity ratio has reduced from 16% to 1.5% over the past 5 years.
Debt Coverage: 002826's debt is well covered by operating cash flow (1716.3%).
Interest Coverage: 002826 earns more interest than it pays, so coverage of interest payments is not a concern.